Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Famotidine vs Placebo for Non-Hospitalized COVID-19
NCT04724720Phase 2Completed
- Sponsor
- Northwell Health
- Start
- Jan 2021
- Primary completion
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of famotidine in coronavirus disease 2019 (COVID-19), sponsored by Northwell Health. Started Jan 2021; status: completed.
02
Drugs
famotidine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04724720.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04724720.